II
EW icon

Inspire Investing’s Edwards Lifesciences EW Stock Holding History

Inspire Investing’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-14,242
Closed -$1.05M – 829
2024
Q4 		$1.05M Buy
14,242
+4,096
+40% +$287K 0.12% 199
2024
Q3 		$670K Sell
10,146
-842
-8% -$61.2K 0.07% 291
2024
Q2 		$1.01M Buy
+10,988
New +$973K 0.12% 209
2023
Q4 		– Sell
-3,584
Closed -$248K – 798
2023
Q3 		$248K Sell
3,584
-75,948
-95% -$6.1M 0.03% 785
2023
Q2 		$7.5M Buy
79,532
+2,673
+3% +$232K 0.91% 12
2023
Q1 		$6.36M Buy
76,859
+6,320
+9% +$497K 0.81% 16
2022
Q4 		$5.26M Buy
70,539
+3,242
+5% +$250K 0.68% 19
2022
Q3 		$5.56M Buy
67,297
+177
+0.3% +$17K 0.79% 14
2022
Q2 		$6.38M Sell
67,120
-8,961
-12% -$928K 0.85% 16
2022
Q1 		$8.96M Sell
76,081
-5,741
-7% -$644K 1.04% 13
2021
Q4 		$10.6M Buy
81,822
+9,666
+13% +$1.13M 1.22% 11
2021
Q3 		$8.17M Buy
72,156
+22,782
+46% +$2.6M 1.03% 13
2021
Q2 		$5.11M Buy
49,374
+4,196
+9% +$396K 0.67% 24
2021
Q1 		$3.78M Buy
45,178
+17,388
+63% +$1.47M 0.58% 27
2020
Q4 		$2.54M Buy
27,790
+4,095
+17% +$340K 0.56% 26
2020
Q3 		$1.89M Buy
23,695
+18,584
+364% +$1.45M 0.52% 34
2020
Q2 		$353K Sell
5,111
-178
-3% -$12.7K 0.12% 179
2020
Q1 		$333K Sell
5,289
-2,004
-27% -$145K 0.13% 196
2019
Q4 		$567K Sell
7,293
-837
-10% -$65.4K 0.2% 165
2019
Q3 		$596K Sell
8,130
-1,551
-16% -$109K 0.23% 122
2019
Q2 		$596K Buy
9,681
+195
+2% +$11.8K 0.25% 104
2019
Q1 		$605K Buy
9,486
+1,938
+26% +$111K 0.28% 88
2018
Q4 		$385K Sell
7,548
-1,080
-13% -$54.6K 0.26% 89
2018
Q3 		$501K Buy
8,628
+546
+7% +$26.7K 0.31% 72
2018
Q2 		$392K Buy
8,082
+186
+2% +$8.68K 0.28% 79
2018
Q1 		$367K Buy
7,896
+2,619
+50% +$114K 0.37% 25
2017
Q4 		$198K Buy
+5,277
New +$194K 0.17% 79

Other funds holding EW

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Inspire Investing's EW Position: Q1 2025 in Review

Inspire Investing sold out of Edwards Lifesciences (EW) in Q1 2025, closing a stake of 14,242 shares — an estimated $1.05M sold.

Inspire Investing first reported a position in EW in Q4 2017 and held it in 27 quarters. The position peaked at $10.6M in Q4 2021. 1,206 funds tracked by Wall St. Rank hold EW as of Q1 2025.

  • Inspire Investing reported no remaining Edwards Lifesciences position as of Q1 2025 after selling out during the quarter.
  • Inspire Investing sold 14,242 Edwards Lifesciences shares in Q1 2025, an estimated $1.05M.
  • Inspire Investing first reported a position in Edwards Lifesciences in Q4 2017 and held it in 27 quarters.
  • Inspire Investing's Edwards Lifesciences position peaked at $10.6M in Q4 2021.
  • 1,206 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2025.

Based on Inspire Investing's 13F filing for Q1 2025, filed 3 Jun 2025.